TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Cadrenal Therapeutics, Inc. ( (CVKD) ) is now available.
On December 1, 2025, Cadrenal Therapeutics announced the appointment of Dr. Lee Scott Golden to its Board of Directors. Dr. Golden brings over 25 years of experience in clinical development, particularly in cardiovascular medicine and anticoagulation, aligning with the company’s mission to advance safer anticoagulant options. His expertise is expected to guide Cadrenal’s strategy and clinical programs, potentially enhancing its industry positioning and value for shareholders.
The most recent analyst rating on (CVKD) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Cadrenal Therapeutics, Inc. stock, see the CVKD Stock Forecast page.
Spark’s Take on CVKD Stock
According to Spark, TipRanks’ AI Analyst, CVKD is a Underperform.
The overall score reflects significant financial challenges, including ongoing losses and no revenue generation, which weigh heavily on the company’s outlook. Technical indicators suggest limited momentum, while valuation metrics highlight difficulties in assessing the stock’s fair value. Despite a positive corporate development with the appointment of a new Chief Medical Officer, the fundamental financial weaknesses remain the dominant concern.
To see Spark’s full report on CVKD stock, click here.
More about Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. is a biopharmaceutical company focused on developing novel anticoagulant therapies to address gaps in current acute and chronic anticoagulation treatments. The company aims to provide solutions with greater predictability, stability, and fewer bleeding complications, targeting underserved patient populations with products like tecarfarin and frunexian.
Average Trading Volume: 23,733
Technical Sentiment Signal: Sell
Current Market Cap: $19.49M
For an in-depth examination of CVKD stock, go to TipRanks’ Overview page.